Upper tract chemoablation (mitomycin gel)
A chemotherapy gel, mitomycin, placed into the kidney's drainage system once a week for 6 weeks through a thin tube, to treat low-grade cancer of the kidney lining without removing the kidney.
Also called Jelmyto, mitomycin gel, mitomycin for pyelocalyceal solution, UGN-101, pyelocalyceal chemotherapy, chemoablation of the kidney, chemo gel in the kidney, kidney-sparing treatment for UTUC
- Where
- Operating room or procedure room with X-ray
- Anesthesia
- Usually general anesthesia or sedation through the bladder route; often little or none through a nephrostomy tube
- Time in the room
- About 20 to 45 minutes for each treatment
- Hospital stay
- Same day
- Back to normal
- Usually the next day
- Back to work
- Often the next day; plan time off for each weekly treatment over 6 weeks
Overview
The kidney collects urine in small cups called calyces and a funnel called the renal pelvis, which drains down the ureter to the bladder. These are lined by the urothelium, the same lining as the bladder. Cancer that grows from this lining inside the kidney is called upper tract urothelial cancer. When it is low grade, meaning slow growing and unlikely to spread, the kidney can often be kept.
Upper tract chemoablation uses mitomycin, a chemotherapy medicine used for decades in the bladder, mixed into a special gel. The gel is liquid when cold and turns into a soft gel at body temperature. Once placed in the kidney, it stays in contact with the tumor for hours instead of washing out in minutes, then slowly melts and passes out in the urine. The medicine is sold as Jelmyto and was approved by the U.S. Food and Drug Administration in 2020 for low-grade upper tract urothelial cancer.
The treatment is given once a week for 6 weeks. Each time, a thin catheter is passed up the ureter from the bladder with a scope, usually with anesthesia, or the gel is given through a nephrostomy tube, a small tube placed through the back into the kidney. About 3 months after starting, your urologist looks inside the kidney with a scope to see whether the tumor is gone.
In the main study that led to approval, about 6 in 10 people had no visible tumor at that check. The most important side effect is narrowing of the ureter, called ureteral stenosis, which can block the kidney and may need a stent. Teams have adjusted how they give the treatment to lower that risk.
The parts of your body involved
Inside each kidney, urine collects in several small cups, the calyces, which join into the renal pelvis, a funnel that narrows into the ureter. The whole system is lined by urothelium. Low-grade tumors here often look like small fronds of seaweed growing from the lining. Because the system has many branches and corners, a scope and laser cannot always reach every tumor, which is where a gel that fills the whole space helps. The ureter is narrow, about the width of a drinking straw, so swelling or scarring in it can block urine flow.
- Calyces
The small cups where urine first collects. The gel fills these to reach tumors in corners.
- Renal pelvis
The funnel that gathers urine from the calyces. A common place for these tumors.
- Urothelium
The lining where the tumor grows and which the gel coats.
- Ureter
The tube to the bladder that the catheter passes through. It can narrow as a side effect.
- Cortex
The outer filtering part of the kidney, which is preserved.
Why it’s done
The goal is to clear low-grade tumors while keeping the kidney and its function.
- Keeping the kidney
Low-grade tumors rarely spread, so removing the whole kidney and ureter may be more than is needed.
- Tumors hard to reach with a laser
The gel fills every cup and corner, reaching tumors a scope cannot fully treat.
- One kidney or weak kidneys
If you have only one kidney or reduced kidney function, removing a kidney could mean dialysis.
- Tumors keep coming back
Some people have repeated low-grade tumors after laser treatment.
- Avoiding a major operation
For people with other health problems, a series of short treatments may be safer than surgery.
Other options
- Laser treatment with a scope
Ureteroscopy with laser can treat small, few, reachable low-grade tumors, followed by regular scope checks. It is often done first, and can be combined with the gel.
- Nephroureterectomy
Removing the kidney, ureter and a small cuff of bladder. It is the standard treatment for high-grade tumors and for low-grade tumors that cannot be controlled with kidney-sparing treatment.
- Removing part of the ureter
For some tumors in the lower ureter, that segment can be removed and the ureter rejoined to the bladder.
- Treatment through the back
For some larger tumors in the kidney, a scope placed through the back into the kidney can remove them.
Getting ready
Tick items off as you go. Your checklist is saved on this device only.
Weeks before
The day before each treatment
The morning of each treatment
In the operating room, step by step
Press play or pick a step. Each drawing shows what your surgeon is doing at that moment. Your team may do some steps differently.
1. Getting set up
You lie on your back with your legs in padded supports. Most people are given anesthesia or sedation for this route. An X-ray machine is positioned over your belly.
After the operation
Right afterward
- Recovery
You rest for 1 to 2 hours after anesthesia or sedation, then go home with a driver.
- First urination
Burning, urgency and tinted urine are common afterward.
- Pain
A mild ache in the side is common as the gel melts and drains. Acetaminophen usually helps.
- Going home
Same day, once you are awake and can urinate.
At home
- Handling urine safely
For the rest of the day of treatment, or the time your team gives, sit down to urinate, close the lid and flush twice, and wash your hands and genital skin with soap and water. This protects your skin and others from the medicine.
- If urine splashes
Wash skin that touches urine with soap and water. Wash soiled clothes separately.
- Fluids
Follow your team's advice. After the gel has had time to work, drinking normally helps flush it out.
- Side pain
A mild ache in the side for a day can happen as the gel drains. Severe or lasting pain may mean the ureter is blocked; call your team.
- Urinary symptoms
Burning, frequent urination and a little blood can last a day or two after each treatment.
- Tiredness and nausea
Some people feel tired or queasy for a day.
- Activity and work
Most people return to normal activity and work the next day.
- Sex
Ask your team whether to use condoms or avoid sex for a day or two after each treatment. Use reliable birth control during the treatment course and for some months after, because mitomycin can harm an unborn baby.
Recovery timeline
- Weeks beforeDiagnosis and preparation
Ureteroscopy with biopsy confirms low-grade tumors; larger tumors are often lasered first.
- Weeks 1 to 6Weekly treatments
One gel treatment each week for 6 weeks, each a short same-day visit.
- After each treatmentA day of symptoms
Burning, frequent urination and a mild side ache for about a day.
- About 3 months from the startFirst check
Ureteroscopy shows whether the tumors are gone.
- Months 4 to 14Maintenance, if chosen
Some people with a complete response receive monthly doses for up to about a year.
- Long termRegular checks
Scope checks of the kidney and bladder and imaging continue for years, because these tumors can come back.
What it feels like
Most people find the weekly routine more tiring than any single treatment. The day after each one can bring bladder irritation, and many people worry about narrowing of the ureter.
Choosing to keep the kidney
Relief at avoiding a major operation, mixed with worry about whether the cancer will come back.
What helpsAsk your team how they will check for recurrence and what the plan would be if tumors return.
The first treatment
Nervousness about the scope and the chemotherapy, and not knowing what to expect.
What helpsAsk the team to walk you through the steps. Most people find later treatments easier once they know the routine.
The evening after
Burning when urinating, frequent trips to the bathroom, a dull ache in the side, and colored urine that can be alarming the first time.
What helpsAcetaminophen, sitting to urinate, and knowing the color is expected all help. These symptoms usually ease within a day.
Weeks 4 to 6
The weekly visits and anesthesia start to wear on people, and fatigue builds.
What helpsPlan lighter days after each treatment. Ask about the nephrostomy route if the scope route is hard on you.
The check scope
Anxiety about whether the treatment worked.
What helpsAsk to hear the findings as soon as you are awake and to have a follow-up visit to review biopsies.
How well it works
Success means no visible tumor at the follow-up scope, and staying tumor-free with regular checks.
- Complete response
In the main study, about 6 in 10 people had no visible tumor at the check about 3 months after starting treatment.
- Lasting response
Many people who responded were still tumor-free a year later, though tumors can come back and need more treatment.
- Biopsies
Biopsies at the check confirm whether any tumor is left and that it is still low grade.
- Ongoing surveillance
Regular ureteroscopy or imaging of the kidney, and cystoscopy of the bladder, continue for years.
- Kidney function
Blood tests check that your kidney function stays stable.
Risks
Every operation has risks. These are the ones people ask about most, with honest odds where good numbers exist. Your surgeon’s own results matter more than averages.
Common
Scarring or swelling can narrow the ureter and block the kidney. It may need a stent, a thin tube inside the ureter, sometimes long term. In the main study about 4 in 10 people had some narrowing; changes in technique aim to lower this.
Usually mild and short-lived after each treatment.
Treated with antibiotics.
Common for a day or two after each treatment.
Usually mild.
Less common
Usually from blockage of the ureter; often improves when the blockage is relieved.
To relieve narrowing or blockage.
An infection in a blocked kidney can spread to the blood and needs urgent treatment.
May need more laser treatment, more gel, or removal of the kidney and ureter.
Rare
A small amount of mitomycin can be absorbed into the blood.
Rash or swelling, rarely severe.
From the catheter or scope.
Call your care team or go to the emergency room if
- Fever of 101°F (38.3°C) or higher, or shaking chills
- Severe side or back pain, or pain that keeps getting worse
- Much less urine than usual, or unable to urinate
- Thick red urine or clots
- Vomiting that will not stop
- Rash, swelling of the face or trouble breathing (call 911 if severe)
- If you have a nephrostomy tube: the tube falls out, leaks around the skin, or stops draining
Questions to ask your surgeon
- Are my tumors definitely low grade?
- Is this a better choice for me than laser treatment alone or removing the kidney?
- Will you give the gel from below or through a nephrostomy tube?
- How many patients have you treated this way?
- What do you do to lower the risk of ureter narrowing?
- Will I need a stent at any point?
- What should I do with my urine and toilet after each treatment?
- Will I need monthly maintenance treatments?
- How will you check for tumors coming back, and how often?
- Should I be tested for Lynch syndrome?
Words you may hear
- Upper tract urothelial cancer
- Cancer of the lining of the kidney's drainage system or the ureter.
- Low grade
- Cancer cells that look closer to normal and tend to grow slowly and rarely spread.
- Mitomycin
- A chemotherapy medicine long used inside the bladder, now also in a gel for the kidney.
- Chemoablation
- Destroying tumors by placing chemotherapy directly on them.
- Pyelocalyceal system
- The renal pelvis and calyces together: the kidney's urine-collecting system.
- Retrograde
- Given from below, through a catheter passed up the ureter from the bladder.
- Antegrade
- Given from above, through a nephrostomy tube in the back.
- Nephrostomy tube
- A small tube through the skin of the back into the kidney.
- Ureteral stenosis
- Narrowing of the ureter that can block urine flow.
- Ureteroscopy
- Looking inside the ureter and kidney with a thin scope.
- Complete response
- No visible tumor left after treatment.
- Maintenance
- Extra doses given after a complete response to try to keep tumors from coming back.
Common questions
Is this chemotherapy like the kind that makes your hair fall out?
No. The medicine stays mostly inside the kidney and very little reaches the rest of the body. Hair loss and serious whole-body side effects are rare.
Can this be used for high-grade cancer?
No. It is approved for low-grade tumors. High-grade tumors are more likely to spread and usually need surgery to remove the kidney and ureter.
Will I need a stent?
Not usually at the start. If the ureter narrows, a stent may be placed to keep urine draining. Ask your team how they watch for this.
What if the tumor does not go away?
Your urologist may treat what is left with a laser, repeat the gel treatment, or recommend removing the kidney and ureter, depending on what the biopsies show.
Why is my urine a strange color?
Mitomycin is a blue-violet medicine, so it can tint your urine blue or violet for a day or two. This is expected.
Will the cancer come back?
It can. Tumors of the lining tend to recur, in the kidney or the bladder, which is why regular checks with a scope continue for years.
Sources this page draws on
- U.S. Food and Drug Administration, Prescribing information: Jelmyto (mitomycin) for pyelocalyceal solution (2020)
- The Lancet Oncology, OLYMPUS phase 3 trial: primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (Kleinmann et al.) (2020)
- American Urological Association and Society of Urologic Oncology, Diagnosis and Management of Non-Metastatic Upper Tract Urothelial Carcinoma: AUA/SUO Guideline (2023)
- European Association of Urology, EAU Guidelines on Upper Urinary Tract Urothelial Carcinoma
Written November 2026. This page explains what usually happens. It is not medical advice and does not replace a conversation with your own surgeon, whose plan for you comes first.